Published Date: 10 Mar 2023
China: A recent study by BMC Medicine has shown that the amount of insoluble fiber from various foods plays an important role...
Read Full NewsA secondary analysis of the DISTAL trial found endovascular therapy's benefit depended more on stroke severity than on prior thrombolysis treatment.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 23, 2026.
A Canadian cohort found modestly greater preeclampsia risk after donation, though most pregnancies were uncomplicated.
Future pregnancy plans don’t preclude living kidney donation, but candidates should be counseled on gestational hypertension risk.
Sparsentan Lowers Inflammatory, Complement Biomarkers in IgAN
Tegoprubart Improves Quality of Life vs Tacrolimus After Kidney Transplant
1.
Renewing the call for a national Cancer Patient's Bill of Rights
2.
TRK Inhibitor Active in Treatment-Refractory Glioblastoma
3.
US to Loosen Marijuana Rules in Major Shift for $47 Billion Industry
4.
Liquid Biopsies Cut EBV Burkitt Lymphoma Time to Diagnosis
5.
Research uncovers hidden Australian skin cancer epidemic
1.
Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training
2.
Enhancing Cancer Care: From Diagnosis Through Survivorship and Beyond
3.
The Power of White Blood Cells: How They Help Keep Us Healthy
4.
AI Meets the Gut Microbiome: Early Detection of GI Malignancies Redefined
5.
Managing High Potassium Levels: A Comprehensive Guide to Veltassa
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
3.
Navigating the Complexities of Ph Negative ALL - Part XVI
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation